Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor
Abstract The prognosis of recurrent malignant peripheral nerve sheath tumors (MPNST) is dismal, with surgical resection being the only definitive salvage therapy.Treatment with chemoradiation approaches has not significantly improved patient outcomes.Similarly, trials of therapies targeting MPNST genomic drivers have thus far been unsuccessful.Impr